論文

査読有り
2020年8月8日

[Elevation of cerebrospinal fluid anti-cyclic citrullinated peptides antibody index is useful for rheumatoid meningitis preceding neurological symptoms without arthritis: a case report].

Rinsho shinkeigaku = Clinical neurology
  • Minako Yamaoka
  • ,
  • Tesseki Izumi
  • ,
  • Nobuyuki Eura
  • ,
  • Ryota Sasaki
  • ,
  • Takao Kiriyama
  • ,
  • Kazuma Sugie

60
9
開始ページ
631
終了ページ
635
記述言語
日本語
掲載種別
研究論文(学術雑誌)
DOI
10.5692/clinicalneurol.cn-001458

We report a 62-year-old female with rheumatoid meningitis. She presented with mental disorder, loss of consciousness, generalized seizures, and cognitive impairment. Brain MRI demonstrated high intensity lesions and abnormal enhancement along the left frontal and parietal sulci. Her serum and cerebrospinal fluid were positive for anti-cyclic citrullinated peptides (CCP) antibody, and the antibody index of cerebrospinal fluid anti-CCP antibody increased, which led us to suspect rheumatoid meningitis. Her symptoms improved immediately by methylpredonisolone pulse therapy and anti-CCP antibody turned negative in cerebrospinal fluid. However, she revealed arthritis with the reduction of betamethasone and was diagnosed as rheumatoid arthritis. We suggest that the elevation of antibody index of cerebrospinal fluid anti-CCP antibody is useful in the diagnosis of rheumatoid meningitis preceding neurological symptoms without arthritis, and anti-CCP antibody in cerebrospinal fluid may be helpful as the evaluation of the treatment.

リンク情報
DOI
https://doi.org/10.5692/clinicalneurol.cn-001458
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/32779602
ID情報
  • DOI : 10.5692/clinicalneurol.cn-001458
  • PubMed ID : 32779602

エクスポート
BibTeX RIS